» Articles » PMID: 28560105

The Metabolic Profile of a Rat Model of Chronic Kidney Disease

Overview
Journal PeerJ
Date 2017 Jun 1
PMID 28560105
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The kidney is always subjected to high metabolic demand. The aim of this study was to characterize metabolic profiles of a rat model of chronic kidney disease (CKD) with cardiorenal syndrome (CRS) induced by prolonged hypertension.

Methods: We used inbred male Dahl salt-sensitive (DS) rats fed an 8% NaCl diet from six weeks of age (high-salt; HS group) or a 0.3% NaCl diet as controls (low-salt; LS group). We analyzed function, pathology, metabolome, and the gene expression related to energy metabolism of the kidney.

Results: DS rats with a high-salt diet showed hypertension at 11 weeks of age and elevated serum levels of creatinine and blood urea nitrogen with heart failure at 21 weeks of age. The fibrotic area in the kidneys increased at 21 weeks of age. In addition, gene expression related to mitochondrial function was largely decreased. The levels of citrate and isocitrate increased and the gene expression of alpha-ketoglutaratedehydrogenase and succinyl-CoA synthetase decreased; these are enzymes that metabolize citrate and isocitrate, respectively. In addition, the levels of succinate and acetyl Co-A, both of which are metabolites of the tricarboxylic acid (TCA) cycle, decreased.

Conclusions: DS rats fed a high-salt diet were deemed a suitable model of CKD with CRS. Gene expression and metabolites related to energy metabolism and mitochondria in the kidney significantly changed in DS rats with hypertension in accordance with the progression of renal injury.

Citing Articles

Nephrectomy and high-salt diet inducing pulmonary hypertension and kidney damage by increasing Ang II concentration in rats.

Jiang Q, Yang Q, Zhang C, Hou C, Hong W, Du M Respir Res. 2024; 25(1):288.

PMID: 39080603 PMC: 11290206. DOI: 10.1186/s12931-024-02916-w.


DNA methylation of miR-181a-5p mediated by DNMT3b drives renal interstitial fibrosis developed from acute kidney injury.

Liu H, Deng Y, Luo G, Yang Y, Xie B, Diao H Epigenomics. 2024; 16(13):945-960.

PMID: 39023272 PMC: 11370974. DOI: 10.1080/17501911.2024.2370229.


Canagliflozin attenuates kidney injury, gut-derived toxins, and gut microbiota imbalance in high-salt diet-fed Dahl salt-sensitive rats.

He L, Zuo Q, Ma S, Zhang G, Wang Z, Zhang T Ren Fail. 2024; 46(1):2300314.

PMID: 38189082 PMC: 10776083. DOI: 10.1080/0886022X.2023.2300314.


Effects of Exercise Training on Mitochondrial Fatty Acid β-Oxidation in the Kidneys of Dahl Salt-Sensitive Rats.

Namai-Takahashi A, Takahashi J, Ogawa Y, Sakuyama A, Xu L, Miura T Int J Mol Sci. 2023; 24(21).

PMID: 37958585 PMC: 10649976. DOI: 10.3390/ijms242115601.


Metabolic Responses of Normal Rat Kidneys to a High Salt Intake.

Shimada S, Hoffmann B, Yang C, Kurth T, Greene A, Liang M Function (Oxf). 2023; 4(5):zqad031.

PMID: 37575482 PMC: 10413938. DOI: 10.1093/function/zqad031.


References
1.
Soga T, Ohashi Y, Ueno Y, Naraoka H, Tomita M, Nishioka T . Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. J Proteome Res. 2003; 2(5):488-94. DOI: 10.1021/pr034020m. View

2.
van Timmeren M, Bakker S, Vaidya V, Bailly V, Schuurs T, Damman J . Tubular kidney injury molecule-1 in protein-overload nephropathy. Am J Physiol Renal Physiol. 2006; 291(2):F456-64. DOI: 10.1152/ajprenal.00403.2005. View

3.
Bidani A, Griffin K . Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension. 2004; 44(5):595-601. DOI: 10.1161/01.HYP.0000145180.38707.84. View

4.
Che R, Yuan Y, Huang S, Zhang A . Mitochondrial dysfunction in the pathophysiology of renal diseases. Am J Physiol Renal Physiol. 2013; 306(4):F367-78. DOI: 10.1152/ajprenal.00571.2013. View

5.
Morooka H, Iwanaga Y, Tamaki Y, Takase T, Akahoshi Y, Nakano Y . Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure. Circ Heart Fail. 2012; 5(4):484-92. DOI: 10.1161/CIRCHEARTFAILURE.111.965392. View